中藏药产品
Search documents
为了百万甘孜群众的幸福生活—— 写在甘孜藏族自治州成立70周年之际
Si Chuan Ri Bao· 2026-01-04 06:14
9月的甘孜高原,处处洋溢着丰收的喜悦。 在甘孜藏族自治州70年的发展历程中,2020年注定会被铭记。今年2月,随着最后一批12个县退出 贫困名单,甘孜州全域全面脱贫摘帽。这是发展史上的丰收。 1950年11月24日,甘孜藏族自治州成立,这是新中国第一个专区级少数民族自治州。70年来,甘孜 各族儿女在中国共产党领导下,从废除封建农奴制度、改革开放,到打赢精准脱贫攻坚战、破题乡村振 兴、建设甘孜新区,一路收获。 站在庆祝建州70年的新起点,落实不久前召开的中央第七次西藏工作座谈会擘画的美好新蓝图。冲 锋号再次吹响,甘孜全力开启建设美丽生态和谐小康甘孜的新征程。 民生优先 只为老百姓幸福生活 如今,石渠县真达乡傲一村的四郎拥措奶奶过得很舒心。去年,33岁的小儿子根腰成功脱贫后,搬 进新房迎娶新娘,了却了四郎拥措奶奶最大的心事。德格县龚垭乡雨拖村根秋措一家也很开心,2017年 以来,在扶贫政策支持下,全家年收入逐步增加到8万多元。 幸福生活,从数据可窥一斑。甘孜州经济总量从1950年的3400万元增长到2019年的388.46亿元;人 均GDP从1950年的66元增长到2019年的32440元;城镇居民人均可支配收入 ...
西藏利众院:扎根高原,以创新驱动中藏药产业发展
Zhong Guo Chan Ye Jing Ji Xin Xi Wang· 2025-05-30 07:07
Core Insights - The article highlights the growth and development of Tibet Lizhongyuan Biotechnology Co., Ltd. as a leading player in the traditional Tibetan medicine industry, supported by Kunming Pharmaceutical Group since 2010 [1][2]. Group 1: Resource Integration - Tibet Lizhongyuan has established a robust capital and technical support system, with Kunming Pharmaceutical Group holding a 75% stake, allowing for effective integration of high-quality medicinal resources and modern production technologies [2]. - The company has built a complete industry chain from medicinal material cultivation to processing and distribution, benefiting from a favorable corporate tax rate of 15% in Tibet, which helps reduce operational costs [2]. Group 2: Diversified Development - The company has expanded its business into various sectors, including traditional Tibetan medicine, antibiotics, biopharmaceuticals, health products, cosmetics, and beverages, showcasing a diversified development strategy [3]. - Tibet Lizhongyuan is also exploring emerging fields such as ecological tourism and agricultural product trade, enhancing its industry structure and market presence [3]. Group 3: Financial Performance - Financial data indicates that Tibet Lizhongyuan has maintained steady growth, with a revenue of 297 million yuan and a net profit of 3.459 million yuan in the first half of 2019, alongside stable cash flow exceeding 30 million yuan [4]. - As of 2023, the company's asset scale has surpassed 38 million yuan, positioning it as a benchmark enterprise in the Tibetan pharmaceutical sector [4]. Group 4: Heritage and Innovation - The company emphasizes the integration of traditional Tibetan medicine wisdom with modern technology, aiming to create an internationally influential ethnic medicine brand [5]. - Through continuous technological innovation and product upgrades, Tibet Lizhongyuan has launched a series of proprietary Tibetan medicine products, gaining widespread market recognition [5]. - Looking ahead, the company plans to leverage its resource advantages and deepen collaboration with Kunming Pharmaceutical Group to promote high-quality development in the Tibetan medicine industry [5].